These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 33255414)

  • 1. Dysregulated Wnt Signalling in the Alzheimer's Brain.
    Aghaizu ND; Jin H; Whiting PJ
    Brain Sci; 2020 Nov; 10(12):. PubMed ID: 33255414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer's disease, restores synapse integrity and memory in a disease mouse model.
    Martin Flores N; Podpolny M; McLeod F; Workman I; Crawford K; Ivanov D; Leonenko G; Escott-Price V; Salinas PC
    Elife; 2024 Jan; 12():. PubMed ID: 38285009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer's Disease.
    Yang Y; Zhang Z
    Front Aging Neurosci; 2020; 12():110. PubMed ID: 32477095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Wnt/β-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer's disease.
    Wang Q; Huang X; Su Y; Yin G; Wang S; Yu B; Li H; Qi J; Chen H; Zeng W; Zhang K; Verkhratsky A; Niu J; Yi C
    Brain; 2022 Dec; 145(12):4474-4488. PubMed ID: 35788280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dickkopf-related protein-1 inhibition attenuates amyloid-beta pathology associated to Alzheimer's disease.
    Menet R; Bourassa P; Calon F; ElAli A
    Neurochem Int; 2020 Dec; 141():104881. PubMed ID: 33068684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of canonical Wnt signaling is involved in the pathogenesis of Alzheimer's disease.
    Tapia-Rojas C; Inestrosa NC
    Neural Regen Res; 2018 Oct; 13(10):1705-1710. PubMed ID: 30136680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for APP in Wnt signalling links synapse loss with β-amyloid production.
    Elliott C; Rojo AI; Ribe E; Broadstock M; Xia W; Morin P; Semenov M; Baillie G; Cuadrado A; Al-Shawi R; Ballard CG; Simons P; Killick R
    Transl Psychiatry; 2018 Sep; 8(1):179. PubMed ID: 30232325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer's disease.
    Jia L; Piña-Crespo J; Li Y
    Mol Brain; 2019 Dec; 12(1):104. PubMed ID: 31801553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NGF and the Amyloid Precursor Protein in Alzheimer's Disease: From Molecular Players to Neuronal Circuits.
    Triaca V; Ruberti F; Canu N
    Adv Exp Med Biol; 2021; 1331():145-165. PubMed ID: 34453297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.
    Tapia-Rojas C; Inestrosa NC
    J Neurochem; 2018 Feb; 144(4):443-465. PubMed ID: 29240990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglial Expression of the Wnt Signaling Modulator
    Aghaizu ND; Jolly S; Samra SK; Kalmar B; Craessaerts K; Greensmith L; Salinas PC; De Strooper B; Whiting PJ
    eNeuro; 2023 Jan; 10(1):. PubMed ID: 36599670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WNT Signaling Is a Key Player in Alzheimer's Disease.
    Inestrosa NC; Tapia-Rojas C; Cerpa W; Cisternas P; Zolezzi JM
    Handb Exp Pharmacol; 2021; 269():357-382. PubMed ID: 34486097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt signalling is a relevant pathway contributing to amyloid beta- peptide-mediated neuropathology in Alzheimer's disease.
    da Cruz e Silva OA; Henriques AG; Domingues SC; da Cruz e Silva EF
    CNS Neurol Disord Drug Targets; 2010 Dec; 9(6):720-6. PubMed ID: 20942790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular properties underlying regional vulnerability to Alzheimer's disease pathology.
    Grothe MJ; Sepulcre J; Gonzalez-Escamilla G; Jelistratova I; Schöll M; Hansson O; Teipel SJ;
    Brain; 2018 Sep; 141(9):2755-2771. PubMed ID: 30016411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Multifaceted Role of WNT Signaling in Alzheimer's Disease Onset and Age-Related Progression.
    Kostes WW; Brafman DA
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonic hedgehog signalling pathway contributes in age-related disorders and Alzheimer's disease.
    Parashar A; Jha D; Mehta V; Chauhan B; Ghosh P; Deb PK; Jaiswal M; Prajapati SK
    Ageing Res Rev; 2024 Apr; 96():102271. PubMed ID: 38492808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt is here! Could Wnt signalling be promoted to protect against Alzheimer disease?: An Editorial for 'Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20- APP transgenic and wild-type mice' on doi:10.1111/jnc.14278.
    Garner B; Ooi L
    J Neurochem; 2018 Feb; 144(4):356-359. PubMed ID: 29372570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
    Kurz C; Walker L; Rauchmann BS; Perneczky R
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes.
    Pluta R; Jabłoński M; Ułamek-Kozioł M; Kocki J; Brzozowska J; Januszewski S; Furmaga-Jabłońska W; Bogucka-Kocka A; Maciejewski R; Czuczwar SJ
    Mol Neurobiol; 2013 Dec; 48(3):500-15. PubMed ID: 23519520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of neurotoxicants in the pathogenesis of Alzheimer's disease: a mechanistic insight.
    Nisa FY; Rahman MA; Hossen MA; Khan MF; Khan MAN; Majid M; Sultana F; Haque MA
    Ann Med; 2021 Dec; 53(1):1476-1501. PubMed ID: 34433343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.